These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 19863370

  • 1. Combination of formoterol and tiotropium in the treatment of COPD: effects on lung function.
    Cazzola M, Tashkin DP.
    COPD; 2009 Oct; 6(5):404-15. PubMed ID: 19863370
    [Abstract] [Full Text] [Related]

  • 2. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.
    van Noord JA, Aumann JL, Janssens E, Verhaert J, Smeets JJ, Mueller A, Cornelissen PJ.
    Chest; 2006 Mar; 129(3):509-17. PubMed ID: 16537846
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.
    Hanania NA, Boota A, Kerwin E, Tomlinson L, Denis-Mize K.
    Drugs; 2009 Jun 18; 69(9):1205-16. PubMed ID: 19537837
    [Abstract] [Full Text] [Related]

  • 4. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ, Keating GM.
    Treat Respir Med; 2004 Jun 18; 3(4):247-68. PubMed ID: 15350163
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.
    Buhl R, Gessner C, Schuermann W, Foerster K, Sieder C, Hiltl S, Korn S.
    Thorax; 2015 Apr 18; 70(4):311-9. PubMed ID: 25677679
    [Abstract] [Full Text] [Related]

  • 6. Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?
    Tennant RC, Erin EM, Barnes PJ, Hansel TT.
    Curr Opin Pharmacol; 2003 Jun 18; 3(3):270-6. PubMed ID: 12810191
    [Abstract] [Full Text] [Related]

  • 7. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA, Cates CJ.
    Cochrane Database Syst Rev; 2015 Oct 22; (10):CD008989. PubMed ID: 26490945
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD.
    Cazzola M, Di Marco F, Santus P, Boveri B, Verga M, Matera MG, Centanni S.
    Pulm Pharmacol Ther; 2004 Oct 22; 17(1):35-9. PubMed ID: 14643169
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S, Eberlein M, Eckhoff J, Schirren J.
    Eur J Cardiothorac Surg; 2011 Jun 22; 39(6):995-1000. PubMed ID: 20970351
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Formoterol and tiotropium compared with tiotropium alone for treatment of COPD.
    Tashkin DP, Pearle J, Iezzoni D, Varghese ST.
    COPD; 2009 Feb 22; 6(1):17-25. PubMed ID: 19229704
    [Abstract] [Full Text] [Related]

  • 15. Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD.
    Salvi S, Brashier B, Gothi D, Karkhanis V, Madas S, Gogtay J, Joshi J.
    Pulm Pharmacol Ther; 2014 Feb 22; 27(1):90-5. PubMed ID: 23752057
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease.
    Cramer JA, Bradley-Kennedy C, Scalera A.
    Can Respir J; 2007 Feb 22; 14(1):25-9. PubMed ID: 17315055
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.
    Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, Kessler R.
    Am J Respir Crit Care Med; 2009 Oct 15; 180(8):741-50. PubMed ID: 19644045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.